Scholars@Duke
Journal cover image

Re: CRISPR/Cas9-Mediated Metabolic Pathway Reprogramming in a Novel Humanized Rat Model Ameliorates Primary Hyperoxaluria Type 1.

Publication ,  Journal Article
Assimos, DG
Published in: J Urol
November 2020
Published version (DOI) Link to item

Duke Scholars

Dean George Assimos
Author Dean George Assimos Urology

Published In

J Urol

DOI

10.1097/JU.0000000000001258.04

EISSN

1527-3792

Publication Date

November 2020

Volume

204

Issue

5

Start / End Page

1092

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Rats
  • Metabolic Networks and Pathways
  • Hyperoxaluria, Primary
  • CRISPR-Cas Systems
  • Animals
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Assimos, D. G. (2020). Re: CRISPR/Cas9-Mediated Metabolic Pathway Reprogramming in a Novel Humanized Rat Model Ameliorates Primary Hyperoxaluria Type 1. J Urol, 204(5), 1092. https://doi.org/10.1097/JU.0000000000001258.04
Assimos, Dean G. “Re: CRISPR/Cas9-Mediated Metabolic Pathway Reprogramming in a Novel Humanized Rat Model Ameliorates Primary Hyperoxaluria Type 1.” J Urol 204, no. 5 (November 2020): 1092. https://doi.org/10.1097/JU.0000000000001258.04.
Assimos, Dean G. “Re: CRISPR/Cas9-Mediated Metabolic Pathway Reprogramming in a Novel Humanized Rat Model Ameliorates Primary Hyperoxaluria Type 1.” J Urol, vol. 204, no. 5, Nov. 2020, p. 1092. Pubmed, doi:10.1097/JU.0000000000001258.04.
Journal cover image

Published In

J Urol

DOI

10.1097/JU.0000000000001258.04

EISSN

1527-3792

Publication Date

November 2020

Volume

204

Issue

5

Start / End Page

1092

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Rats
  • Metabolic Networks and Pathways
  • Hyperoxaluria, Primary
  • CRISPR-Cas Systems
  • Animals
  • 3202 Clinical sciences
  • 1103 Clinical Sciences